SFTW Investor - Stock Detail (Guest User)

Guest users are limited to viewing 2 stocks profiles per day. You have 1 view(s) left. Click here to create a free SFTW Investor account for unlimited access to stock information and additional features like watchlist and recommendations.

REGN - Regeneron Pharmaceuticals, Inc.

safety score
87
Healthcare - Biotechnology
HOLD
safety score
87
ADD  
fundamental metrics
Market cap : 40.59B
EBITDA : 1.44B
PEG Ratio (TTM) : 0.43
CURRENT YEAR [ ESTIMATE ]
EPS : 12.94
Price per EPS : 29.56
NEXT YEAR [ ESTIMATE ]
EPS : 15.52
Price per sales : 8.33
Fundamental metrics are indicators that are used primarily by value investors to help determine a company's intrinsic worth. We can use this data to help guide us in the investment process to buy company shares at prices that give us a high margin of safety over the long term.

REGN ranks in the 87 percentile within our entire stock database of over 2000 companies. We divide our entire database into 8 different sectors. This stock is in the Healthcare and we rank Healthcare as 3 out of our 8 sectors. REGN ranks in the 86 percentile within the Healthcare sector. We divide the Healthcare sector into 15 specific industry groups. REGN is in the Biotechnology industry group. We rank REGN number 7 out of 74 stocks within its specific industry group.
See how a stock has performed over time. Select the date range at the top of the graph or use the blue scroller at the bottom of the graph to select the range you want to see. Mouseover anywhere on the time axis to see the stock price on a particular day. You can choose to view only Buy alerts, Sell alerts or both.
If you had acted on the SFTW Investor recommendation of Buy on 09 Aug 2016, your return would have been 15.97% less than investing in an index fund based on the S&P 500.
LEARN MORE
Regeneron Pharmaceuticals, Inc. Newsfeed